THURMAN RANDY H (CIK 1204059) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-27). Recent activity: Buy OTLK (5,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-27 | Outlook Therapeutics, Inc. (OTLK) | Director | Buy | 5,000 | $2,145 |
Source: SEC Form 4 filings · as of 2026-05-27